Vita Life Sciences Limited (ASX:VLS)
2.440
0.00 (0.00%)
Jul 30, 2026, 4:10 PM AEST
Vita Life Sciences Market Cap
Vita Life Sciences has a market cap or net worth of 132.69 million as of July 31, 2026. Its market cap has increased by 7.16% in one year.
Market Cap
132.69M
Enterprise Value
99.43M
Revenue
93.27M
Ranking
n/a
PE Ratio
13.30
Stock Price
2.44
ChartMarket Cap Chart
Since August 23, 2007, Vita Life Sciences's market cap has increased from 2.18M to 132.69M, an increase of 5,979.24%. That is a compound annual growth rate of 24.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 132.69M | -5.84% |
| Dec 31, 2025 | 140.92M | 26.53% |
| Dec 31, 2024 | 111.37M | 16.19% |
| Dec 27, 2023 | 95.85M | 25.15% |
| Dec 21, 2022 | 76.59M | -26.95% |
| Dec 31, 2021 | 104.86M | 93.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Little Green Pharma | 61.50M |
| Medical Developments International | 51.26M |
| Syntara | 43.16M |
| Peak Processing | 21.26M |
| Vitura Health | 17.23M |
| IDT Australia | 14.11M |
| ECS Botanics Holdings | 9.58M |
| Epsilon Healthcare | 8.95M |